San Francisco-based startup Rune Labs said Monday that it has received withdrawal From the US Food and Drug Administration for using the Apple Watch to monitor tremors and other common symptoms in patients with Parkinson’s disease.
rune labs Uses motion sensor built in software apple watch, which can be used to detect when a person has fallen. Rune Labs chief executive Brian Pepin said in an interview that Apple Watch data will be combined with data from other sources, including a Medtronic implant that can measure brain signals.
Rune Labs aims to use combined data for doctors to decide exactly how and when to treat patients. Currently, Pepin said, most doctors have to collect data on a patient’s movements during a short clinical visit, which is not ideal because Parkinson’s symptoms can vary widely over time.
Using the Apple Watch, Rune Labs’ StrivePD software platform will provide doctors with a continuous stream of observation over a long period of time, Pepin said.
“When you think about the process of getting someone for their optimal therapy or combination of drugs or devices, or even whether a patient is a good fit for a certain clinical trial Whether or not it’s a very difficult decision when you only have a little context,” Pepin said.
Last year, a group of Apple scientists published a study in the journal Science Translational Medicine showing that the device was effective in monitoring Parkinson’s symptoms. After contacting Apple about the tool, Pepin said, “It took about eight minutes for the team lead to come back to me and say, ‘Hey, right, let’s explore this.'”
Apple has partnered with several other companies to use the Apple Watch as a health monitoring device, including a deal with Johnson & Johnson to study whether its use can help lower the risk of stroke. to be done.
© Thomson Reuters 2022